123 related articles for article (PubMed ID: 23734736)
1. The majority of newly generated cells in the adult mouse substantia nigra express low levels of Doublecortin, but their proliferation is unaffected by 6-OHDA-induced nigral lesion or Minocycline-mediated inhibition of neuroinflammation.
Worlitzer MM; Viel T; Jacobs AH; Schwamborn JC
Eur J Neurosci; 2013 Sep; 38(5):2684-92. PubMed ID: 23734736
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal stem cells augment neurogenesis in the subventricular zone and enhance differentiation of neural precursor cells into dopaminergic neurons in the substantia nigra of a parkinsonian model.
Park HJ; Shin JY; Lee BR; Kim HO; Lee PH
Cell Transplant; 2012; 21(8):1629-40. PubMed ID: 22546197
[TBL] [Abstract][Full Text] [Related]
3. Newborn dopaminergic neurons are associated with the migration and differentiation of SVZ-derived neural progenitors in a 6-hydroxydopamin-injected mouse model.
Xie MQ; Chen ZC; Zhang P; Huang HJ; Wang TT; Ding YQ; Qi SS; Zhang C; Chen SX; Zhou P; Shao CC; Liao M; Sun CY
Neuroscience; 2017 Jun; 352():64-78. PubMed ID: 28385636
[TBL] [Abstract][Full Text] [Related]
4. Selegiline normalizes, while l-DOPA sustains the increased number of dopamine neurons in the olfactory bulb in a 6-OHDA mouse model of Parkinson's disease.
Chiu WH; Carlsson T; Depboylu C; Höglinger GU; Oertel WH; Ries V
Neuropharmacology; 2014 Apr; 79():212-21. PubMed ID: 24291466
[TBL] [Abstract][Full Text] [Related]
5. Environmental enrichment brings a beneficial effect on beam walking and enhances the migration of doublecortin-positive cells following striatal lesions in rats.
Urakawa S; Hida H; Masuda T; Misumi S; Kim TS; Nishino H
Neuroscience; 2007 Feb; 144(3):920-33. PubMed ID: 17161913
[TBL] [Abstract][Full Text] [Related]
6. 6-hydroxydopamine-induced Parkinson's disease-like degeneration generates acute microgliosis and astrogliosis in the nigrostriatal system but no bioluminescence imaging-detectable alteration in adult neurogenesis.
Fricke IB; Viel T; Worlitzer MM; Collmann FM; Vrachimis A; Faust A; Wachsmuth L; Faber C; Dollé F; Kuhlmann MT; Schäfers K; Hermann S; Schwamborn JC; Jacobs AH
Eur J Neurosci; 2016 May; 43(10):1352-65. PubMed ID: 26950181
[TBL] [Abstract][Full Text] [Related]
7. Increased progenitor cell proliferation and astrogenesis in the partial progressive 6-hydroxydopamine model of Parkinson's disease.
Aponso PM; Faull RL; Connor B
Neuroscience; 2008 Feb; 151(4):1142-53. PubMed ID: 18201835
[TBL] [Abstract][Full Text] [Related]
8. Anti-inflammatory treatment induced regenerative oligodendrogenesis in parkinsonian mice.
Worlitzer MM; Bunk EC; Hemmer K; Schwamborn JC
Stem Cell Res Ther; 2012 Aug; 3(4):33. PubMed ID: 22892385
[TBL] [Abstract][Full Text] [Related]
9. Enriched environment induces cellular plasticity in the adult substantia nigra and improves motor behavior function in the 6-OHDA rat model of Parkinson's disease.
Steiner B; Winter C; Hosman K; Siebert E; Kempermann G; Petrus DS; Kupsch A
Exp Neurol; 2006 Jun; 199(2):291-300. PubMed ID: 16360152
[TBL] [Abstract][Full Text] [Related]
10. Myricitrin Ameliorates 6-Hydroxydopamine-Induced Dopaminergic Neuronal Loss in the Substantia Nigra of Mouse Brain.
Kim HD; Jeong KH; Jung UJ; Kim SR
J Med Food; 2016 Apr; 19(4):374-82. PubMed ID: 26991235
[TBL] [Abstract][Full Text] [Related]
11. Peptide hormone exendin-4 stimulates subventricular zone neurogenesis in the adult rodent brain and induces recovery in an animal model of Parkinson's disease.
Bertilsson G; Patrone C; Zachrisson O; Andersson A; Dannaeus K; Heidrich J; Kortesmaa J; Mercer A; Nielsen E; Rönnholm H; Wikström L
J Neurosci Res; 2008 Feb; 86(2):326-38. PubMed ID: 17803225
[TBL] [Abstract][Full Text] [Related]
12. Rosiglitazone, a PPAR-γ agonist, protects against striatal dopaminergic neurodegeneration induced by 6-OHDA lesions in the substantia nigra of rats.
Lee EY; Lee JE; Park JH; Shin IC; Koh HC
Toxicol Lett; 2012 Sep; 213(3):332-44. PubMed ID: 22842585
[TBL] [Abstract][Full Text] [Related]
13. Indomethacin promotes survival of new neurons in the adult murine hippocampus accompanied by anti-inflammatory effects following MPTP-induced dopamine depletion.
Hain EG; Sparenberg M; Rasińska J; Klein C; Akyüz L; Steiner B
J Neuroinflammation; 2018 May; 15(1):162. PubMed ID: 29803225
[TBL] [Abstract][Full Text] [Related]
14. The proliferative capacity of the subventricular zone is maintained in the parkinsonian brain.
van den Berge SA; van Strien ME; Korecka JA; Dijkstra AA; Sluijs JA; Kooijman L; Eggers R; De Filippis L; Vescovi AL; Verhaagen J; van de Berg WD; Hol EM
Brain; 2011 Nov; 134(Pt 11):3249-63. PubMed ID: 22075520
[TBL] [Abstract][Full Text] [Related]
15. Astrocyte delivery of glial cell line-derived neurotrophic factor in a mouse model of Parkinson's disease.
Cunningham LA; Su C
Exp Neurol; 2002 Apr; 174(2):230-42. PubMed ID: 11922664
[TBL] [Abstract][Full Text] [Related]
16. Fibroblast growth factor 2 enhances striatal and nigral neurogenesis in the acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.
Peng J; Xie L; Jin K; Greenberg DA; Andersen JK
Neuroscience; 2008 May; 153(3):664-70. PubMed ID: 18407421
[TBL] [Abstract][Full Text] [Related]
17. Nestin-positive/SOX2-negative cells mediate adult neurogenesis of nigral dopaminergic neurons in mice.
Albright JE; Stojkovska I; Rahman AA; Brown CJ; Morrison BE
Neurosci Lett; 2016 Feb; 615():50-4. PubMed ID: 26806039
[TBL] [Abstract][Full Text] [Related]
18. Full and partial peroxisome proliferation-activated receptor-γ agonists, but not δ agonist, rescue of dopaminergic neurons in the 6-OHDA parkinsonian model is associated with inhibition of microglial activation and MMP expression.
Sadeghian M; Marinova-Mutafchieva L; Broom L; Davis JB; Virley D; Medhurst AD; Dexter DT
J Neuroimmunol; 2012 May; 246(1-2):69-77. PubMed ID: 22498097
[TBL] [Abstract][Full Text] [Related]
19. Osteopontin expression in activated glial cells following mechanical- or toxin-induced nigral dopaminergic cell loss.
Iczkiewicz J; Rose S; Jenner P
Exp Neurol; 2007 Sep; 207(1):95-106. PubMed ID: 17643430
[TBL] [Abstract][Full Text] [Related]
20. Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms.
Perier C; Bender A; García-Arumí E; Melià MJ; Bové J; Laub C; Klopstock T; Elstner M; Mounsey RB; Teismann P; Prolla T; Andreu AL; Vila M
Brain; 2013 Aug; 136(Pt 8):2369-78. PubMed ID: 23884809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
